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Article focus
  Mechanisms of bone regeneration via pri­
mary macrophage–mesenchymal stem 
cell (MSC) interaction in an in vitro cocul­
ture model.
  Temporal modulation of proinflam­
matory (M1) to anti­inflammatory (M2) 
polarization to maximize MSC matrix 
mineralization.
  Sex differences between cells derived 
from male and female mice.
Key messages
  Bone mineralization at four weeks is high­
est with interleukin (Il)­4 addition at 96 
hours in male cocultures and 72 hours in 
female cocultures.
  Early and late osteogenic markers were 
en hanced with Il­4 addition later in male 
cocul tures compared with female cocultures.
  The sex of the cells had a statistically sig­
nificant effect on the optimal time for Il­4 
addition for osteogenesis.
precise immunomodulation of the M1 
to M2 macrophage transition enhances 
mesenchymal stem cell osteogenesis 
and differs by sex
Objectives
Up to 10% of fractures result in undesirable outcomes, for which female sex is a risk factor. 
cellular sex differences have been implicated in these different healing processes. Better 
understanding of the mechanisms underlying bone healing and sex differences in this pro-
cess is key to improved clinical outcomes. This study utilized a macrophage–mesenchymal 
stem cell (Msc) coculture system to determine: 1) the precise timing of proinflammatory 
(M1) to anti-inflammatory (M2) macrophage transition for optimal bone formation; and 2) 
how such immunomodulation was affected by male versus female cocultures.
Methods
A primary murine macrophage-Msc coculture system was used to demonstrate the optimal 
transition time from M1 to M2 (polarized from M1 with interleukin (IL)-4) macrophages 
to maximize matrix mineralization in male and female Mscs. outcome variables included 
Alizarin Red staining, alkaline phosphatase (ALp) activity, and osteocalcin protein secretion.
Results
We found that 96 hours of M1 phenotype in male cocultures allowed for maximum matrix 
mineralization versus 72 hours in female cocultures. ALp activity and osteocalcin secretion 
were also enhanced with the addition of IL-4 later in male versus female groups. The sex of 
the cells had a statistically significant effect on the optimal IL-4 addition time to maximize 
osteogenesis.
Conclusion
These results suggest that: 1) a 72- to 96-hour proinflammatory environment is critical for 
optimal matrix mineralization; and 2) there are immunological differences in this cocul-
ture environment due to sex. optimizing immunomodulation during fracture healing may 
enhance and expedite the bone regeneration response. These findings provide insight into 
precise immunomodulation for enhanced bone healing that is sex-specific.
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Strengths and limitations
  This study demonstrated the temporal effect of M1 to 
M2 polarization on MSC matrix mineralization in pri­
mary murine coculture system.
  This is the first study to examine and demonstrate dif­
ferences in macrophage­MSC interactions based on 
the sex of the cells.
  Further studies are needed to explore mechanisms of 
the differences found between cells derived from 
male versus female mice.
introduction
Bone fractures are among the most common injuries 
treated by orthopaedic surgeons, with nearly 3.9 million 
emergency department visits in the United States every 
year.1 These fractures are estimated to cost between $12 
billion and $18 billion in direct healthcare expenditures 
annually. Furthermore, indirect costs associated with 
bone fractures contribute billions of additional dollars. 
With the ageing population, these costs could double or 
triple in the coming decades.2 Many factors contribute to 
the risk of fracture, including age, sex, race, and physiol­
ogy, and similar characteristics are predictive of outcomes 
such as morbidity, death, disability, and cost to the 
healthcare system.3 Even with standard of care treatment, 
between 5% and 10% of fractures result in undesirable 
outcomes, such as delayed healing or nonunion.4­7 Such 
outcomes lead to complex, expensive, and often invasive 
alternative treatment strategies, which place undue bur­
dens on the patient, physician, and society.8
In normal fracture healing, a proinflammatory cas­
cade initiates fracture healing. local and migrating 
macrophages at the site of injury phagocytose debris 
and release cytokines and chemokines, which promote 
angiogenesis, recruit MSCs, and initiate regenerative 
processes.9­11 This proinflammatory process begins 
immediately after injury and peaks at 24 hours. Within 
a few days, the acute inflammatory reaction subsides 
and regenerative mechanisms start to predominate at 
the fracture site.12
Macrophages can be generally categorized into three 
phenotypes: undifferentiated M0, proinflammatory M1, 
and anti­inflammatory M2. These phenotypes exist along 
a spectrum and macrophages are able to transition 
among these phenotypes.13­15 Macrophages can be 
‘polarized’ between these three phenotypes using vari­
ous cytokines. lipopolysaccharide (lPS) is one example 
of a cytokine that may be used to polarize undifferenti­
ated M0 macrophages to the inflammatory M1 state, 
while interleukin (Il)­4 or Il­13 will polarize M0 or M1 
macrophages to the anti­inflammatory M2 state.16­19
Depending on the local immune environment, mac­
rophages are known to affect MSC growth and differen­
tiation. M1 macrophages have been shown to inhibit 
human MSC (hMSC) growth, whereas M2 macrophages 
support hMSC growth.20 However, previous work using 
primary murine MSCs or MC3T3 osteoprogenitor cells 
demonstrated that the addition of M1 macrophages 
enhanced bone mineralization and osteogenesis.21,22 
Moreover, it was shown that initiating the M1 to M2 tran­
sition at 72 hours via the addition of Il­4 resulted in 
enhanced matrix mineralization, alkaline phosphatase 
(AlP) activity, and osteocalcin secretion.22
Interestingly, fracture healing and risk of nonunion 
vary with sex. In elderly populations, men are at higher 
risk for increased morbidity, postoperative complications, 
and mortality after hip fractures, while women are at 
higher risk for developing osteoporosis (a risk factor for 
fractures) and nonunions after femoral neck fractures.23­25 
Following fractures, female rats have biomechanically 
compromised and radiologically delayed bone formation 
compared with male rats, and this effect is even greater in 
aged populations. These differences are, in part, due to a 
decreased number of MSCs in female rats.26,27 Moreover, 
male osterix­mCherry mice with induced mid­femur frac­
tures formed larger calluses and had higher volumetric 
bone mineral density and bone strength than their female 
counterparts.28 Despite the elevated bone mineral den­
sity and bone strength in male mice, the same study 
found that female mice had higher systemic bone forma­
tion than male mice after an induced femur fracture.28 
The sex of the cells has also been shown to affect the 
function of macrophages and MSCs, but little is known of 
the effect of sex on the interaction between MSCs and 
macrophages.29­32
A better understanding of the mechanisms underly­
ing bone regeneration and the role of sex differences in 
this process are key to improved clinical outcomes. Few 
studies have examined the dynamic interplay between 
macrophages and MSCs in a coculture system and none 
have explored the temporal relationship of macrophage 
polarization on MSC osteogenesis.20,21,33,34 There is a 
paucity of literature on the effects of sex on the interac­
tions between macrophages and MSCs. In the present 
study, we used a polarized macrophage­MSC coculture 
system to determine: 1) the precise timing of M1 to M2 
transition for optimal bone formation; and 2) how such 
immunomodulation was affected by male versus female 
cocultures.
Materials and Methods
Mouse primary macrophage isolation. Primary mouse 
macrophages were obtained from the bone marrow of 
five male and five female Jackson C57Bl­6J mice (Jackson 
laboratory, Bar Harbor, Maine) and cells from both sexes 
were treated separately. All mice were eight weeks old 
and therefore had not reached maturity. After extraction 
of hind limb long bones, bone marrow was flushed into 
a 50 ml centrifuge tube with 5 ml of basal medium (RPMI 
1640 (Thermo Fisher Scientific, Waltham, Massachusetts), 
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10% fetal bovine serum (FBS, Thermo Fisher Scientific), 
1× antibiotic­antimycotic (100 units of penicillin, 100 µg 
of streptomycin, and 0.25 µg of amphotericin B per mil­
liliter, HyClone; Thermo Fisher Scientific) with a needle. 
A 70 µm cell strainer was used to filter cells into a sep­
arate tube. This tube was centrifuged at 400 g for ten 
minutes, after which cells were resuspended in 1 ml of 
ice­cold RBC lysis buffer (MilliporeSigma, Burlington, 
Massachusetts) for two minutes at 4°C; 20 ml of basal 
medium was then added. After centrifugation again 
at 400 g for ten minutes, cells were resuspended in 5 
ml of augmented basal macrophage medium (RPMI 
1640, 30% l929 leucocyte­conditioned medium (lCM, 
medium conditioned by l929 leukocytes in laboratory), 
10% FBS, 1× antibiotic­antimycotic, and 10 ng/ml mouse 
macrophage colony­stimulating factor (mM­CSF, R&D 
Systems, Minneapolis, Minnesota)). Cells were counted 
and frozen in vials with 10% dimethyl sulfoxide (DMSo, 
vWR, Radnor, Pennsylvania) in serum.
Primary mouse mesenchymal stem cell isolation. Primary 
mouse MSCs were obtained from the bone marrow of 
five eight­week­old male and five eight­week­old female 
Jackson C57Bl­6J mice (Jackson laboratory, Bar Harbor, 
Maine) and cells from both sexes were treated separately. 
All mice were eight weeks old and therefore had not 
reached maturity. After extraction of hind limb long bones, 
bone marrow was flushed into a dish and resuspended in 
MSC growth medium (Minimum Essential Medium Eagle 
alpha (α­MEM, Thermo Fisher Scientific), 10% heat inacti­
vated MSC qualified FBS, 1× antibiotic­antimycotic) using 
a needle. A 70 µm cell strainer was used to filter cells 
into a separate tube. This tube was centrifuged at 400 
g for five minutes, after which cells were resuspended in 
medium and plated onto 175 cm2 culture flasks. MSCs 
were cultured in an incubator for three to four weeks 
with regular medium changes. When confluent, cells 
were washed with Dulbecco’s phosphate­ buffered saline 
(DPBS, Thermo Fisher Scientific) and detached by incu­
bating in trypsin for two minutes. Detached cells were 
flushed with 10 ml of medium and spun at 400 g for five 
minutes, after which cells were resuspended and plated 
at a 4000 cells/ cm2 density. This was repeated for four to 
seven passages, until MSCs were counted and frozen in 
vials with 10% DMSo in serum.
Macrophage-MSC coculture and macrophage polariza-
tion. Frozen macrophages and MSCs were reconstituted 
in macrophage and MSC growth medium, respectively, 
and expanded to the desired cell number separately. 
Macrophages were polarized to M1 by 24­hour exposure 
to 100 ng/ml lipopolysaccharide (lPS, Sigma­Aldrich, St. 
louis, Missouri) in macrophage medium, following pre­
viously established protocols.22,35 Polarized M1 macro­
phages and primary MSCs were plated concurrently in a 
5:1 ratio (50 000 macrophages:10 000 MSCs) in a 24­well 
plate. The coculture system utilized a mixed osteogenic­
macrophage medium comprised 50% osteogenic and 
50% macrophage medium (44.5% α­MEM, 38.5% RPMI 
1640, 10% MSC FBS, 5% lCM, 1% antibiotic­antimycotic, 
1% Glutamax (life Technologies, Carlsbad, California) 
supplemented with 50 µg/ml l­ascorbic acid, 0.01 M β­
glycerophosphate, and 10 nM dexamethasone (all from 
life Technologies). After plating of cocultures, Il­4 (20 
ng/ml, R&D Systems) was added to coculture groups 
at 24­hour intervals (0, 24, 48, 72, and 96 hours after 
plating; Fig. 1). This polarization technique with lPS and 
Il­4 has been previously shown to produce M1 and M2 
phenotypes reliably via flow cytometry, quantitative real­
time polymerase chain reaction (qRT­PCR), and cytokine 
secretion profile.22,35,36
Control groups included a negative control group 
(MSCs alone in MSC growth medium), a positive control 
group (MSCs alone in mixed osteogenic/macrophage 
M1
macrophage
MSC
No IL-4
 Analysis
1) ALP activity at week 2
2) Alizarin Red staining at week 4
3) Osteocalcin ELISA at week 4
+ IL-4
+ IL-4
+ IL-4
+ IL-4
+ IL-4
24 hrs
48 hrs
72 hrs
96 hrs
Fig. 1
Schematic demonstrating experimental methodology. Proinflammatory macrophages (M1s) were plated with mesenchymal stem cells (MSCs), at which point 
interleukin (Il)­4 was added immediately, after 24 hours, after 48 hours, after 72 hours, or after 96 hours. Controls included M1s cultured with MSCs with no 
Il­4 added, a negative control (MSCs alone in nonosteogenic growth media, not shown), and a positive control (MSCs alone in mixed osteogenic­macrophage 
media, not shown). osteogenesis outcome measures included alkaline phosphatase (AlP) activity at two weeks, Alizarin Red staining at four weeks, and osteo­
calcin secretion at four weeks. ElISA, enzyme­linked immunosorbent assay.
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medium), and an M1­MSC control group without Il­4. 
With all three osteogenic outcome measures (Alizarin Red 
staining, AlP activity, and osteocalcin secretion), it was 
shown that the positive control groups exhibited signifi­
cantly greater osteogenesis than the negative control 
groups, providing validation of the osteogenesis model 
(Supplementary Figures a, b, and c).
Detecting osteogenic markers. Alkaline phosphatase (AlP) 
activity was measured in cell lysates at two weeks after the 
beginning of cocultures using the QuanitChrom Alkaline 
Phosphatase Assay Kit (DAlP­250, BioAssaySystems, 
Hayward, California). An enzyme­linked immunosor­
bent assay (ElISA) for osteocalcin was performed on 
cell supernatants collected at four weeks using the 
Mouse osteocalcin ElISA Kit (Alfa Aesar, Haverhill, 
Massachusetts).
Alizarin Red staining. Alizarin Red staining was used to 
measure osteogenesis at four weeks. The cells were rinsed 
with DPBS followed by fixation in 2% paraformaldehyde 
(vWR) for ten minutes at room temperature. DPBS was 
used to rinse cells twice, after which 40 mM Alizarin Red 
solution (pH 4.1 to 4.3, Sigma­Aldrich) was used to stain 
cells on a rocker for 15 minutes. The cells were washed 
three times with deionized water on a rocker for five min­
utes each wash. Plates were imaged and 1 ml of 10% 
cetylpyridinium chloride destain solution was added to 
each well and placed on a rocker for one hour. Samples 
were transferred to a 96­well plate, and absorbance at 
562 nm was read in triplicate.
Statistical analysis. In order to analyze the effect of the 
Il­4 addition at various timepoints on osteogenesis, 
a one­way analysis of variance (ANovA) followed by 
Tukey’s post hoc test was performed using GraphPad 
Prism (GraphPad, San Diego, California), with p < 0.05 
selected as the threshold for statistical significance. A 
two­way ANovA was also performed to analyze the 
effect of the sex of the cells on osteogenesis with varying 
Il­4 timepoints. Bar graphs are presented as mean and 
standard deviation.
Results
Bone mineralization at four weeks. Alizarin Red stain­
ing of the male coculture system at four weeks (Fig. 2a) 
showed significantly increased matrix mineralization 
after addition of Il­4 at 96 hours compared with all other 
groups (p < 0.001). In the female coculture (Fig. 2b), 
Alizarin Red staining at four weeks showed significantly 
increased matrix mineralization after addition of Il­4 at 
72 hours compared with all other groups (p < 0.001). In 
the female coculture, the 0­hour Il­4 group showed sig­
nificantly increased matrix mineralization compared with 
the M1­MSC and 48­hour Il­4 groups (p < 0.01).
Alkaline phosphatase activity at four weeks. In the male 
coculture system (Fig. 3a), Il­4 added at 96 hours resulted 
in significantly higher AlP activity than all other groups 
(p < 0.01). Additionally, the 0­hour Il­4 group showed 
significantly increased AlP activity compared with the 
M1­MSC and 48­hour Il­4 groups (p < 0.05). In female 
cocultures (Fig. 3b), addition of Il­4 at 48 and 72 hours 
resulted in significantly increased AlP activity compared 
with Il­4 added at 0 or 24 hours (p < 0.01). The 96­hour 
Il­4 group was also found to have significantly higher 
AlP activity than the 24­hour Il­4 group (p < 0.05), but 
not the 0­hour Il­4 group.
Osteocalcin secretion at four weeks. In male cocultures 
(Fig. 4a), the addition of Il­4 at 72 and 96 hours resulted 
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Bone matrix mineralization was measured via Alizarin Red staining at week 4. a) The male cells showed significantly increased bone mineralization after addi­
tion of interleukin (Il)­4 at 96 hours compared with all other groups (p < 0.001). b) In the female coculture, addition of Il­4 at 72 hours showed significantly 
increased Alizarin Red staining compared with all other groups (p < 0.001). *Statistically significant difference from groups indicated by black bar. †Statistically 
significant difference from all other groups. M1, proinflammatory macrophage; MSC, mesenchymal stem cell.
485Precise immunomodulation of the m1 to m2 macroPhage transition
vol. 8, No. 10, oCToBER 2019
in significantly higher osteocalcin secretion at four weeks 
than all other groups (p < 0.05 for 72­hour Il­4; p < 0.01 
for 96­hour Il­4). In female cocultures (Fig. 4b), the addi­
tion of Il­4 at 72 hours resulted in significantly higher 
osteocalcin secretion than all other groups (p < 0.01). 
Furthermore, addition of Il­4 at 96 hours resulted in sig­
nificantly increased osteocalcin secretion compared with 
all groups except the 24­hour Il­4 group (p < 0.05) and 
significantly decreased osteocalcin secretion compared 
with the 72­hour Il­4 group (p < 0.01).
Sex of the cells had a significant effect on osteogenesis. A 
two­way ANovA was performed to compare the inter­
action effect between sex of the cells and timing of Il­4 
addition on Alizarin Red staining, AlP activity, and osteo­
calcin secretion. For Alizarin Red staining, the interaction 
effect yielded an F ratio of F(5,36) = 39.00 (p < 0.001). 
For AlP activity, the interaction effect yielded an F ratio 
of F(5,36) = 17.48 (p < 0.001) and for osteocalcin secre­
tion, the interaction effect yielded an F ratio of F(5,36) = 
14.52 (p < 0.001). This confirms that sex of the cells does 
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Alkaline phosphatase (AlP) activity at week 2. a) Interleukin (Il)­4 added at 96 hours to the male coculture resulted in significantly higher AlP activity than all 
other groups (p < 0.01). b) The female coculture showed that adding Il­4 at 48 and 72 hours resulted in significantly increased AlP activity compared with Il­4 
added at 0 or 24 hours (p < 0.01). The 96­hour Il­4 group was also found to have significantly higher AlP activity than the 24­hour Il­4 group (p < 0.05), but 
not the 0­hour Il­4 group. *Statistically significant difference from groups indicated by black bars. †Statistically significant difference from all other groups. M1, 
proinflammatory macrophage; MSC, mesenchymal stem cell.
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Fig. 4b
osteocalcin secretion via enzyme­linked immunosorbent assay (ElISA) at four weeks. a) The addition of interleukin (Il)­4 at 72 and 96 hours in the male cocul­
ture resulted in significantly higher osteocalcin secretion at four weeks than all other groups (p < 0.05 for 72­hour Il­4; p < 0.01 for 96­hour Il­4). b) In the 
female cells, adding Il­4 at 72 hours resulted in significantly higher osteocalcin secretion than all other groups (p < 0.01). Addition of Il­4 at 96 hours resulted 
in significantly decreased osteocalcin secretion compared with the 72­hour Il­4 group (p < 0.01). *Statistically significant difference from groups indicated by 
black bars. †Statistically significant difference from all other groups. ‡Statistically significant difference from all other groups except female 24­hour Il­4. M1, 
proinflammatory macrophage; MSC, mesenchymal stem cell.
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significantly affect all three osteogenesis outcome vari­
ables regarding the timing of Il­4 addition.
Discussion
The bone formation process is dependent on crosstalk 
between macrophages and MSCs and is characterized by 
an initial M1­mediated proinflammatory period, followed 
by an M2­mediated anti­inflammatory period.10,37 This 
study was designed to model the transition between 
these two vital periods by adding Il­4 to an M1­MSC 
coculture at various timepoints to determine the optimal 
time for the M1 to M2 transition.
Using male cells, adding Il­4 at 96 hours led to 
increased matrix mineralization, AlP activity, and osteoc­
alcin secretion. However, using female cells, adding Il­4 
earlier at 72 hours resulted in the highest levels of matrix 
mineralization, AlP activity, and osteocalcin secretion. 
These results reiterate that a finite proinflammatory 
period is necessary prior to transition between the M1­ 
and M2­mediated phases in a macrophage­osteoprogen­
itor cell coculture system.22 Moreover, we found that this 
optimal time differs between cells derived from male ver-
sus female mice. Thus, the optimal duration of the initial 
inflammatory response for bone regeneration varies by 
sex. of note, AlP activity in female cells was elevated but 
not significantly different among the 48­, 72­, and 
96­hour groups, while male cells showed a marked 
increase in APl activity at 96 hours compared with all 
other groups. However, in the setting of bone fractures, 
where bone mineralization is the most clinically impor­
tant endpoint, the enhanced mineralization (via Alizarin 
Red staining) at 72 hours in the female group should be 
highlighted as the main finding, especially with congru­
ent osteocalcin findings. Although AlP activity is widely 
used as a marker for osteogenesis, it is only actually 
required for the initiation of mineralization, not necessar­
ily for the progression or as a specific indicator of final 
bone formation.38,39
Male cells seem to benefit from a longer inflammatory 
response, while a slightly shorter period of inflammation 
is sufficient for female cells. The three­ to five­day time 
range contains important events for bone regeneration; 
one study showed that there are striking differences 
between cancellous and cortical bone formation that 
occur between days 3 and 5.40 our study also suggests 
that the initial three or four days of macrophage­MSC 
crosstalk and macrophage immunomodulation during 
this time are crucial for enhanced osteogenesis four 
weeks later.
variations between male and female stem cells can 
begin to explain these sex differences. Female stem cells 
have been shown to possess a greater skeletal muscle 
regeneration efficiency, while male stem cells have higher 
osteogenic potential and bone regenerative capacity.29­31 
However, male cells required a longer period of proin­
flammatory exposure than female cells to optimize 
osteogenesis in our coculture system, which suggests 
that the addition of macrophages may contradict previ­
ously established results. one possible mechanism for 
these sex­linked differences is the difference in steroid 
receptors between males and females; these receptors 
are vital contributors to and mediators of stem cell prolif­
eration and differentiation.41
There are also considerable sex­related differences 
with regard to inflammatory disorders in humans, most 
notably the higher incidence of autoimmune diseases 
among women.32,42 These differences are at least in part 
due to leucocyte variations; it has been shown that female 
mice and rats have more macrophages and lymphocytes, 
and female resident macrophages express higher levels 
of toll­like receptors (TlRs), greater phagocytosis capa­
bilities, and enhanced bacterial killing compared with 
their male counterparts. However, it was concurrently 
shown that in vivo exposure of macrophages to live bac­
teria caused less severe sepsis and lower levels of bacteria 
in the blood of female mice, compared with male mice.43
Additionally, several studies have shown that female­
derived cells tend to exist in a lower inflammatory state 
than male cells.44­49 For example, a murine study investi­
gating the acute phase of viral myocarditis demonstrated 
that myocardial infiltrating macrophages in male mice 
were predominantly of the M1 phenotype, while the cor­
responding cells in female mice were predominantly of 
the M2 phenotype.44 Moreover, female macrophages 
produced a greater amount of Il­4, while male mac­
rophages expressed higher levels of interferon­gamma 
(IFN­γ). Interestingly, expression of Il­13, another classi­
cal M2 cytokine, did not differ between the sexes.44 
However, others have shown that higher levels of plasma 
Il­6 are measured in male mice compared with female 
mice following exposure to lPS.45 This suggests that the 
phenotypic differences between male and female mac­
rophages may be specific to certain cytokines.
our study has several limitations: first, this is an in vitro 
study that aims to simplify the complex physiological 
environment in vivo. Especially in the context of sex, our 
coculture model does not account for the systemic hor­
monal differences characteristic for males and females. 
Numerous studies have shown that sex hormones can 
regulate and affect cell growth/apoptosis, migration, and 
function of macrophages in various ways.50­54 This study’s 
coculture model was designed and based on multiple 
prior studies published from our group that had previ­
ously established and validated the macrophage­MSC 
coculture and polarization models.21,22,55 However, future 
in vitro studies should incorporate appropriate sex hor­
mones and progress to an in vivo model to examine the 
effects of sex hormones on macrophage­MSC crosstalk.
Second, though we did not directly measure the effect 
of Il­4 on MSCs alone, a previous study showed that Il­4 
has no effect on Runt­related transcription factor 2 
(RUNX2) and AlP expression in human MSCs.56 Therefore, 
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the enhanced osteogenesis by addition of Il­4 is likely 
mediated via the crosstalk between MSCs and mac­
rophages. Further studies should also explore timepoints 
later than 96 hours. As the male group maximized osteo­
genesis with addition of Il­4 at the final timepoint (96 
hours), it is conceivable that the actual peak lies past 96 
hours. Regardless, it is evident from the current data that 
male MSCs benefit from prolonged M1 exposure com­
pared with female MSCs. Finally, all cells used in this 
study were harvested from young, immature mice. It is 
known that ageing causes intrinsic changes to both mac­
rophages and MSCs.57 Further studies should be done to 
investigate the effect of ageing on both macrophage­
MSC crosstalk and sex differences.
In conclusion, this study found that: 1) precise immu­
nomodulation of the M1 to M2 transition is essential for 
enhanced osteogenesis of MSCs; and 2) this optimal 
inflammatory period differs between male and female 
coculture systems. optimizing immunomodulation dur­
ing fracture healing may enhance and expedite the bone 
regeneration response. Moreover, these results suggest 
that there are sex differences that are associated with 
macrophage­MSC crosstalk in osteogenesis. These differ­
ences at the cellular level may, in part, explain differences 
in bone healing clinically. As inflammation is essential for 
all regenerative processes, our study may have broader 
implications for regeneration in other organ systems and 
the potential differences that may exist due to sex.
Supplementary material
Data for Alizarin Red staining at four weeks, alkaline 
phosphatase activity at two weeks, and osteocalcin 
secretion at two weeks for mesenchymal stem cell (MSC) 
control groups (male or female MSCs cultured alone in 
osteogenic media, with no macrophages or interleukin 4 
added). With all three osteogenic outcome measures, it 
was shown that the positive control groups exhibited sig­
nificantly greater osteogenesis than the negative control 
groups, providing validation of the osteogenesis model.
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